Strata Critical Medical (SRTA) Shares Outstanding (2019 - 2026)

Strata Critical Medical (SRTA) has 8 years of Shares Outstanding data on file, last reported at $86.5 million in Q1 2026.

• Quarterly Shares Outstanding rose 6.85% year-over-year to $86.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $86.5 million (up 6.85% YoY) and the FY2025 annual result came in at $86.7 million, up 9.17% from the prior year.
• Shares Outstanding held at $86.5 million in Q1 2026 per SRTA's latest filing, from $86.7 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $86.7 million in Q4 2025 and bottomed at $70.8 million in Q1 2022.
• The 5-year median for Shares Outstanding is $77.1 million (2024), against an average of $77.4 million.
• Peak annual rise in Shares Outstanding reached 171.27% in 2022, while the deepest fall reached 1.41% in 2022.
• Tracing SRTA's Shares Outstanding over 5 years: stood at $71.7 million in 2022, then gained by 4.84% to $75.1 million in 2023, then increased by 5.71% to $79.4 million in 2024, then gained by 9.17% to $86.7 million in 2025, then decreased by 0.21% to $86.5 million in 2026.
• Per Business Quant, the three latest SRTA Shares Outstanding figures stand at $86.5 million (Q1 2026), $86.7 million (Q4 2025), and $86.1 million (Q3 2025).

Peer Comparison